Please provide your email address to receive an email when new articles are posted on . Just over 50 years has passed since the first total artificial heart was “successfully” implanted into a dog by ...

Please provide your email address to receive an email when new articles are posted on . Machine learning models to predict myocardial recovery among patients who underwent left ventricular assist ...

April 18, 2011 (San Diego, California) — Nearly 50% of patients receiving a left ventricular assist device (LVAD) experience a hospital readmission within 6 months of implantation, and most first-time ...

New York, NY, December 2, 2015 - More left ventricular assist devices (LVADs), a mechanical heart that helps pump blood, are now implanted annually than hearts transplanted in patients with advanced ...

Highlights include the best six month survival documented in a LVAD CE Mark clinical study and low rates of adverse events with zero pump thrombosis events Survival with HeartMate 3 at six months was ...

Patients who developed late right heart failure (RHF) after left ventricular assist device (LVAD) surgery suffered more major adverse events and had worse survival, researchers found. At 1 month ...

This analysis evaluates the relationship between hospital care delivery network fragmentation and in-hospital and 90-day outcomes. These networks may be novel targets for improving outcomes.

The FDA said today that it had granted approval to the HeartWare Ventricular Assist System for use in heart failure patients waiting for a transplant. Approval of the device had been expected after ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

We observed an apparent increase in the rate of device thrombosis among patients who received the HeartMate II left ventricular assist device, as compared with preapproval clinical-trial results and ...

Evidence-based data indicate that left ventricular assist devices (LVADs) have saved many lives. However, starting in 2011 device failures due to clots forming inside these pumps (pump thrombosis) ...